Manufacturing giant Kimberly-Clark is set to acquire Kenvue, the maker of Tylenol, for $48.7 billion. CBS News MoneyWatch correspondent Kelly O'Grady has more details.
Breakdown
- Kimberly-Clark is set to acquire Kenvue, Tylenol's parent company, for nearly $50 billion. 4s
 - The deal is expected to close in the second half of 2026, pending shareholder and government approval. 23s
 - Kimberly-Clark shareholders will own 54% of the combined company, with Kenvue shareholders holding 46%. 38s
 - The merged company is projected to generate $32 billion in annual revenue and achieve $1.9 billion in cost savings. 48s
 - Following the announcement, Kenvue's stock rose over 15%, while Kimberly-Clark's stock fell more than 13%. 1m 40s